一个实用性试验的葡萄糖皮质类药物用于社区获得的肺炎
Ruth K Lucinde1, Henry Gathuri1, Paul Mwaniki1
1Kenya Medical Research Institute-Wellcome Trust Research Program, Kilifi.
The New England journal of medicine
|October 29, 2025
概括
在肯尼亚,辅助性皮质糖类药物显著降低了社区获得的严重肺炎 (CAP) 患者的死亡率. 这种低剂量疗法在资源较少的环境中被证明是有益的,与标准护理相比,减少了死亡率.
科学领域:
- 临床医学 临床医学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的社区性肺炎 (CAP) 构成严重的死亡风险,特别是在资源有限的环境中.
- 辅助葡萄糖皮质激素治疗在资源充足的地区有望降低死亡率.
- 在缺乏资源,医疗保健基础设施有限的环境中,葡萄糖皮质类药物的有效性仍然不确定.
研究的目的:
- 评估辅助低剂量葡萄糖皮质激素治疗在低资源环境下降低严重社区性肺炎 (CAP) 患者死亡率的有效性.
- 评估葡萄糖皮质激素对该群体不良事件的安全性和影响.
主要方法:
- 在肯尼亚的18家公立医院进行了一项务实的,开放的,随机对照试验.
- 被诊断为CAP的成年患者被分配给接受标准护理或标准护理以及口服低剂量葡萄糖皮质类药物10天.
- 衡量的主要结局是注册后30天的所有原因死亡率.
主要成果:
- 总共有2180名患者被随机分配. 在30天后,葡萄糖皮质激素组的死亡率为22.6%,标准治疗组为26.0% (危险比,0.84;P=0.02).
- 两组之间不良事件和严重不良事件的发生率是可比的.
- 严重的不良事件归因于葡萄糖皮质激素的管理是罕见的,发生在0.5%的患者.
结论:
- 在低资源环境中,辅助葡萄糖皮质激素治疗显示,CAP患者的死亡风险显著降低.
- 在资源有限的环境中,低剂量葡萄皮质激素是一种潜在的有益和安全的辅助治疗严重的CAP.
- 进一步的研究可能会探索最佳剂量和长期结果.
更多相关视频
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
692
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
692
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
402
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
402
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:28Pneumonia IV: Management
713
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
713